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Abstract. To identify regions involved in tissue specific 
regulation of transcription of the al (VI) collagen chain, 
transgenic mice were generated carrying various por- 
tions of the gene's 5'-flanking sequence fused to the 
E. coli 13-galactosidase  gene. Analysis of the transgene 
expression pattern by X-gal staining of embryos re- 
vealed that: (a) The proximal 0.6 kb of promoter se- 
quence activated transcription in mesenchymal cells at 
sites of insertion of superficial muscular aponeurosis 
into the skin; tendons were also faintly positive. (b) The 
region between -4.0 and -5.4 kb from the transcrip- 
tion start site was required for activation of the trans- 
gene in nerves. It also drove expression in joints, in in- 
tervertebral disks, and in subepidermal and vibrissae 
mesenchyme. (c) The fragment comprised within -6.2 
and -7.5 kb was necessary for high level transcription 
in skeletal muscle and meninges. Positive cells in mus- 
cle were mostly mononuclear and probably included 
connective tissue elements, although staining of myo- 
blasts was not ruled out. This fragment also activated 
expression in joints, in intervertebral disks, and in sub- 
epidermal and vibrissae mesenchyme. (d) [3-Galactosi- 
dase staining in vibrissae induced by the sequences 
-4.0 to -5.4 and -6.2 to -7.5 was not coincident: with 
the latter sequence labeled nuclei were found mainly in 
the ventral and posterior quadrant, and, histologically, 
in the outer layers of mesenchyme surrounding and be- 
tween the follicles, whereas with the former the remain- 
ing quadrants were positive and expressing cells were 
mostly in the inner layers of the dermal sheath. (e) 
Other tissues, notably lung, adrenal gland, digestive 
tract, which produce high amounts of collagen type VI, 
did not stain for 13-galactosidase.  (f) Central nervous 
system and retina, in which the endogenous gene is in- 
active, expressed the lacZ transgene in most lines. The 
data suggest that transcription of al(VI) in different 
tissues is regulated by distinct sequence elements in a 
modular arrangement, a mechanism which confers high 
flexibility in the temporal and spatial pattern of expres- 
sion during development. 
M 
OST cells of complex organisms are in permanent 
contact  with  the  extracellular  matrix  (ECM)  1, 
an  ordered  architecture  of  macromolecules 
composed of a  variety of secreted proteins and polysac- 
charides. The ECM is the major determinant  of the me- 
chanical  properties of organs and contributes to the main- 
tenance of tissue homeostasis. It has been demonstrated in 
the recent years that several components of the ECM in- 
teract  with  specific cell  surface  receptors  and  that  this 
binding  triggers  rearrangements  of the cytoskeleton and 
intracellular  signal transduction cascades leading to changes 
in cell shape and adhesion, proliferation, gene expression, 
and differentiation  (Juliano and Haskill,  1993). A  major 
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feature  of the  ECM  is  the  preferred  distribution  of its 
components in different tissues and the peculiar variation 
of their expression during development (Adams and Watt, 
1993). Thus, in the embryo, the ECM can be considered as 
an array of signaling molecules which come in contact with 
distinct cell populations in a highly regulated manner and 
influence differentiation and morphogenesis (Lin and Bis- 
sel, 1993). Several experiments in various vertebrate spe- 
cies and gene knock out of integrin receptors in the mouse 
support this view (DeSimone, 1994). 
The above considerations point out that a key question 
in the study of the different components of the ECM is 
how expression is regulated during development in vivo. 
Despite the very high number of ECM genes identified so 
far, data on their in vivo regulation are limited mostly to 
collagen type I (Pavlin et al., 1992; Liska et al., 1994; Ros- 
sert et al.,  1995; Sokolov et al.,  1995; references cited in 
these papers) and type II (Lovell-Badge et al., 1987; Hor- 
ton et al., 1987). In this report we extend this type of infor- 
mation to type VI collagen. This protein, a trimer of three 
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has a short collagenous domain flanked at both sides by a 
large globular domain composed of numerous von Wille- 
brand factor type A repeats (Colombatti et al., 1993). 
Collagen VI is adhesive for several cell types and inter- 
acts with a number of other extracellular molecules, like 
collagen type I, II, and III, biglycan, decorin, and hyaluro- 
nan (Bonaldo et al., 1990; Bidanset et al., 1992; Colombatti 
et al., 1993; Pfaff et al., 1993; Specks et al., 1992), a prop- 
erty suggesting that the protein contributes to the ordered 
organization of the ECM. In the matrix, type VI collagen 
forms a network of microfibrillar aggregates distinct from, 
but often mixed with the banded fibers of type I collagen 
(Bruns et al., 1986). Although the distribution of the two 
collagen types is widely overlapping, important differences 
have been described, including a high ratio of type VI to 
type I collagen in intervertebral disks and articular carti- 
lage, and an opposite proportion in bone and a preferred 
localization of type VI collagen in the pericellular space or 
underneath epithelial cell layers (Keene et al., 1988; Mar- 
vulli et al., 1996). These differences may be important for 
conferring peculiar mechanical properties not only to the 
various tissues, but also to distinct regions within the same 
tissue. An interesting difference between the two collagen 
types has also been revealed by studies on the in vitro dif- 
ferentiation of several cells of mesodermal origin, like adi- 
pocytes, myoblasts, and  chondroblasts: collagen VI,  but 
not I, is transiently expressed at very high levels during the 
initial phase of differentiation (Daniet al., 1989; Ibrahimi 
et al., 1993; Quarto et al., 1993; Piccolo et al., 1995). To 
clarify the mechanisms responsible for tissue specific tran- 
scription  of collagen type VI,  we  have  undertaken  the 
analysis of cis-acting elements of the cd(VI) chain gene in 
vivo. In this study we have identified genomic regions nec- 
essary for high level activation in several tissues. 
Materials and Methods 
DNA Constructs 
The  isolation  and characterization  of a  h  clone  (mG1) for  the mouse 
al(VI) collagen gene has been described (Bonaldo et al., 1993). Two frag- 
ments of mG1  subcloned into  the plasmid Bluescript  (Stratagene, La 
JoUa, CA) were the starting material for the synthesis of the constructs 
used in this study. One SphI fragment contained N7.5 kb of the Y-flank- 
ing sequence of the gene, the first two exons, the first and part of the sec- 
ond intron, and included a PstI fragment extending from base +41 to base 
-1344 from the transcription start site (Bonaldo et al., 1993). For synthe- 
sis of pl.41acZ, the 1.4-kb PstI fragment was inserted into the PstI site of 
pNSlacZ, a  vector which contains the E.  coil I$-galactosidase gene pre- 
ceded by the nuclear localization signal and followed by the polyadenyla- 
tion site of SV40 large T  antigen between the Pstl and BamHI sites of 
pKS-Bluescript. A  fragment extending from  +75  to  -635 was derived 
from the genomic clone by PCR amplification, restriction at the internal 
Pstl site, and insertion into pNSIacZ, producing plasmids p0.61acZ. To 
construct p7.5A(3.0-1.1)lacZ, the fragment extending from -7.5 to -3.0 
kb  was  excised from the  SphI  subclone by  cutting with  NotI  (in  the 
polylinker) and NsiI and insetted into pl.41acZ after removal of the se- 
quence upstream of the NsiI site at -1111 with the same enzymes. The 
NsiI fragment from -3.0 kb to base -1111 was then inserted into the Nsil 
site of p7.5A(3.0-1A)lacZ to give plasmid p7.51acZ. Constructs p6.21acZ, 
p5.41acZ, p4.01acZ, and p2.81acZ were derived by deleting 5' portions of 
p7.51acZ with restriction enzymes HindIII, BamHI, Sinai, and DraI, re- 
spectively (Fig. 1 A). Plasmids p7.5A(6.2-1.4)IacZ, p6.2A(5.4-1.4)lacZ, and 
p5.4A(4.0-1.4)lacZ (Fig. 1 B) were obtained by subcloning the appropriate 
restriction fragment in vector pl.41acZ upstream of the proximal 1.4 pro- 
moter region. 
Production and Identification of Transgenic Mice 
Transgenic mouse lines and embryos were produced from B6D2F1  fe- 
males mated with B6D2F1 males (Charles River Italia or MBS, Treviso, 
Italy) using standard procedures (Hogan et al., 1986).  DNA was microin- 
jected into pronuclei of one-cell embryos and the surviving embryos were 
implanted  into  CD1  pseudopregnant foster  mothers. Transgenic mice 
were identified by analysis of genomic DNA from yolk sac or tail biopsies 
by either PCR using appropriate primers and reaction conditions or the 
dot blot assay. The number of integrated transgene copies of the lines was 
determined by Southern blot analysis using an internal fragment of lacZ 
as probe. To analyze the temporal and spatial pattern of [3-galactosidase 
expression in the established lines, founder or Fl-males were mated with 
B6D2F1 females and embryos isolated at different days of gestation. The 
day  of the  vaginal plug was  designed day  0.5  of gestation. When the 
founder embryos were sacrificed the age was confirmed by staging (Butler 
and Juurlink, 1987). 
Whole Mount LacZ Staining and Histological Analysis 
Embryos were dissected, quickly washed in PBS, and processed for fixa- 
tion and histochemical staining for 13-galactosidase  exactly as described 
(Bonnerot and Nicolas, 1993). The dorsal part of 14.5 d and older embryos 
was cut with a razor blade on a midsagittal plane in order to facilitate pen- 
etration of fixative and staining solutions. After overnight incubation at 
30°C in the staining solution, positive embryos were washed in PBS, pho- 
tographed, fixed for 12-16 h in 4% paraforrnaldehyde in PBS, dehydrated 
in  ethanol,  and  embedded  in  paraffin.  6-10-~m  thick  sections  were 
mounted on gelatinized glass slides, counterstained with hematoxilin and 
eosin and mounted in Permount. All the pictures shown in this paper were 
from embryos excepting Figs. 4 C and 9 E, which were from the leg of an 
adult transgenic mouse. In this case the limb was disarticulated at  the 
coxo-femoral joint and processed for X-gal staining after removal of the 
skin. The samples were then demineralized in 4%  formic acid for one 
week and embedded in paraffin. 
LacZ Staining and Immunofluorescence of 
Frozen Sections 
Embryos were dissected in PBS and the left upper limb was cut out and in- 
dividually processed for lacZ staining as described above. The rest of the 
embryo was frozen in isopentane cooled in liquid nitrogen and kept at 
-80°C. Transgertic embryos were identified the following day by inspec- 
tion of the limbs. 6-10-p,m cryostat sections were collected on gelatin- 
coated glass slides and air dried. For staining, the sections were fixed for 
30 s in acetone, air dried, and incubated overnight in X-gal solution (Bon- 
nerot and Nicolas, 1993)  at room temperature. After washing in PBS, the 
slides were counterstained with hematoxilin and eosin and mounted in 
50% glycerol in PBS. In some experiments sections stained for 13-galac- 
tosidase were treated with the mouse monoctonal antibody iC8 (Vitadello 
and Denis-Donini, 1990)  which recognizes the NF-M subunit of mouse 
neurofilaments and/or  a  rabbit  polyclonal antibody specific for mouse 
type VI collagen (Colombatti et al., 1995). The slides were then incubated 
with  rhodamine-labeled goat  anti-mouse Ig  and/or  fluorescein-labeled 
goat anti-rabbit  Ig, washed, stained with HOECHST dye, mounted in 
50%  glycerol  in  PBS  and  observed  in  a  Zeiss  Axioplan  microscope 
equipped with epifluorescence optics. 
Results 
Generation of Transgenic Mice 
Transgenic mice were generated with [3-galactosidase  con- 
structs comprising various portions of the 5'-flanking re- 
gion of the txl(VI) collagen gene. For initial investigation 
of the pattern of promoter expression, a total of 34 inde- 
pendent expressing lines were generated using the con- 
structs shown in Fig. 1 A. For most lines the founder was 
sacrificed; however, four lines with the longest and one 
with  the  shortest  construct  were  propagated,  allowing 
analysis of transgene expression at different developmen- 
tal ages. No variations in the pattern and the intensity of 
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Figure 1.  Constructs used and transgenic animals generated. Dif- 
ferent portions  of the 5'-flanking  region of the al(VI) collagen 
chain were fused with the E. coli 13-galactosidase gene followed 
by the polyadenylation signal of SV40. (A and B) Constructs used 
to generate transgenic animals analyzed in Table I and Table II, 
respectively. 
transgene expression were observed in different embryos 
of the same established line. At least three lines were pro- 
duced for each construct and, in each group, at least one 
line had multiple copies of the transgene (Table I). 
Expression of Transgenes 
Embryos were whole mount-stained and examined. Serial 
sections were then prepared from each of them and ob- 
served in the microscope. For established transgenic lines, 
cryostat  sections  were  also  prepared  and  subsequently 
stained for [3-galactosidase. Similar results were obtained 
with the two procedures. The main distribution of 13-galac- 
tosidase-producing cells in tissues from the different lines 
is summarized in Table I in parallel with the evaluation of 
collagen VI  expression products in control embryos at 
different locations (Marvulli et al., 1996). Four major cate- 
gories of tissues could be distinguished. In some tissues in 
which the synthesis of type VI collagen is very active, a par- 
ticular construct was  usually expressed or not expressed 
depending on the size of the promoter fragment. These tis- 
sues  included  skin  insertions  of superficial  aponeurosis, 
joints, intervertebral disks, nerves, vibrissae, skeletal mus- 
cle, and meninges where expression was high, and tendons 
and subepidermal mesenchyme where the levels of activity 
of the  reporter gene  were  usually weak.  Expression  in 
these tissues  is described below in detail and is summa- 
rized in Table I. In a second group of tissues, 13-galactosi- 
dase staining was negative in most transgenic animals, al- 
though varying amounts of products (mRNA and protein) 
of the endogenous gene could be demonstrated in their 
connective tissue. This condition was detected in lung, di- 
gestive tract and associated glands, thymus, bladder, kid- 
ney, serosae, adrenal gland, gonads, periostium, and peri- 
chondrium. Examples of the absence of staining in these 
tissues can be found in Fig. 5, D  and E for stomach, adre- 
nal gland, kidney and lung, and in Fig. 6 C for gonads and 
liver. Due to the absence of staining, these organs have not 
been considered in Table I. A  third group comprised of 
tissues such as the central nervous system and the retina, 
which are not collagen VI producers, but which exhibited 
ectopic expression of the transgenes in almost every line 
or embryo investigated. A  summary of this ectopic stain- 
ing has been reported in Table I. Finally, some collagen 
VI-producing tissues randomly expressed the transgenes 
only in a limited set of lines (<20% of total) at low levels 
and with no apparent correlation with the size of the pro- 
moter sequence  of the  construct.  Examples were heart, 
blood vessels, adipose tissue, and cartilage. Although not 
completely negative, the low expression of the transgenes 
in these tissues did not allow a clear analysis of the regula- 
tory regions. These tissues were therefore not included in 
Table I. 
In the following description of 13-galactosidase  expres- 
sion in different tissues the emphasis will be on tissues of 
the first group. The pattern of expression in this group de- 
pended on the size of the regulatory region of the trans- 
gene. As this was increased, staining was found at addi- 
tional sites, in such a way that tissues positive in transgenic 
mice with shorter constructs were usually a  subgroup of 
those positive in animals with longer constructs (Table I). 
Overall, there was a remarkable similarity in the pattern of 
expression of 13-galactosidase  in lines with the same pro- 
moter construct. Variations  were, however, observed in 
the levels of transgene expression between the lines, as es- 
timated by the relative number of X-gal positive nuclei in 
a given tissue (Table I). These differences were apparently 
not related to the transgene copy number and are likely a 
consequence of the site of DNA integration. 
Sites of Insertion of the Superficial  Muscular and Apo- 
neurotic System. Constructs with a 5'-flanking region equal 
to or shorter than 4.0 kb  (0.61acZ,  1.41acZ,  2.81acZ  and 
4.01acZ) gave very similar results (Table I and Fig. 2). In 
embryos of the  line  0.61acZ57,  [3-galactosidase  reaction 
was detectable starting at 12.5 d as a ring in the limb buds, 
which was stronger in the forelimb (Fig. 2 A). Discrete ar- 
eas of staining were also noted just in front of the ear (Fig. 
2 A) and at the armpit and the groin (Fig. 2 B). Staining in- 
creased in intensity in the following days and, at 16.5 d, it 
was restricted to the forearm in the upper limb (Fig. 2 C), 
whereas, in the lower limb, it became a patch with poste- 
rior  location  (Fig.  2  D).  Embryos  transgenic  for  the 
1.41acZ, 2.81acZ, and 4.01acZ constructs produced a similar 
staining. Examples for 1.41acZ  and 2.81acZ  are shown in 
the Fig. 2, E and F. The former was identical to the 0.61acZ 
line. The latter had a very strong reactivity in the ear re- 
gion and, in addition, in the upper and lower eyelids. The 
staining pattern described above was common to all the 
transgenic embryos examined and examples with longer 
constructs can be seen in Figs. 3, 5 A, and 6 B. Microscopic 
examination revealed that  all  these  positive, apparently 
unrelated, regions had a common histological motif, since 
they represented sites of insertion of the superficial apo- 
neurosis which contains the cutaneous muscle (Fig. 3). As 
explained in the Discussion, this tissue has been indicated 
in this study as the Superficial and Muscular Aponeurotic 
System (SMAS). The association of the od(VI) transgenes 
expression with this structure is clearly seen in the parasag- 
Braghetta et al. Tissue Specific Expression of eH  (Vl) Collagen  1165 Table L Main Tissue Distribution of Transgene Expression* 
Tissues 
Age of  Insertion of  Tendons  Vibrissae  CNS 0 
Copy  embryos  superficial  and  Intervertebral  Subepidermal  (mesen-  Skeletal  and/or 
Line  number  (d)  aponeuroses  ligaments  Joints  disks  Nerves  mesenchyme  chyme)  muscle  Meninges  retina 
0.61acZ57  1  13.5;  16.5  +  +  +  .......  +  + 
0.61acZ2 II  13  15.5  +  4-  ........ 
0.61acZ311  8  15.5  +  +  +  +  +  +  .....  +  -  + 
ND  15.5  ++  +  .......  + 
ND  14.5  ++  +++  .......  ++++ 
5  15.5  ++  -  .......  + 
3  15.5  +++  ++  ....  +  -  -  +++ 
1  15.5  +  ++  .......  +++ 
1  14.5  ++  +++  ......  ++  + 
1  14.5  ++  +  .......  + 
1  15.5  ++  ++  .......  ++ 
1  15.5  +  4-  .......  +++ 
8  15.5  ++  +  ....  +  -  -  ++ 
1  15.5  +  4-  .......  +++ 
3  15.5  +  +  4-  ........ 
1  15.5  +++  ++  .......  + 
1  14.5  ++  +  .....  +  -  ++ 
12  15.5  ++++  ++  ___  4-  ++++  +  ++++  4-  +++  +++ 
5  15.5  +  -+  +++  ++  +  4-  4-  -  -  + 
4  15.5  +++  +  ++++  ++++  ++++  +  ++++  -  -  + 
8  15.5  +++  +  ++  ++  ++  +  +  --  --  ++ 
1  14.5  +  +  --  +  +  4-  --  -  --  ++ 
4  14.5  ++++  +  ++  +++  ++++  ++  +++  --  --  +++ 
1  14.5  ++++  +++  ++  +  4-  4-  4-  +  -  ++++ 
1  15.5  ++++  +  ++  ++  +++  4-  +++  -  -  ++ 
1  15.5  ++++  +  ++  ++  +++  --+  +++  -  -  + 
1  15.5  ++  ++  +  +  +++  4-  +  4-  -  +++ 
3  15.5  ++++  +++  ++++  ++++  +++  +  +++  +++  +  ++ 
5  14.5  ++++  ++  ++  ++++  ++++  +  ++++  +  +  ++++ 
3  14.5  ++++  +++  +++  ++++  ++++  +  ++++  +  ++++  ++++ 
4  9.5 to  16.5  +++  ++  ++++  ++++  ++++  +++  ++++  +++  +++  +++ 
6  12.5 to  16.5  +++  ++  +  +  4-  4-  +  +  ++  +++ 
4  11.5 to  16.5  +++  +  ++++  ++++  +++  ++  ++++  ++  +++  ++ 
6  9.5 to  16.5  ++  ++  +++  +++  +  4-  +++  ++  ++  +++ 
++++  +++  ++++  ++++  +++  ++++  ++++  ++++  +++  - 
1.41acZl II 
1.41acZ2 II 
1.41acZ3 II 
2.81acZlU 
2.81acZ2 II 
2.81acZ3n 
2.81acZ411 
4.01acZ1 II 
4.01acZ2 H 
4.01acZ31q 
4.01acZ41J 
4.01acZ5 II 
4.01acZ6 II 
4.01acZTII 
5.41acZt II 
5.41acZ2 II 
5.41acZ3 II 
5.41acZ4PI 
5.41acZ511 
6.21acZ1 II 
6.21acZ2 It 
6.21acZ3 II 
6.21acZ411 
6.21acZ5 II 
7.5A(3.0-1.1)lacZlll 
7.5A(3.0-1.1)lacZ2 II 
7.5A(3.0-1.1)lacZ3 II 
7.51acZ8 
7.51acZ57 
7.51acZ62 
7.51acZ71 
Control I  9.5 to  16.5 
*Intensity of [3-galactosidase staining in each of the 34 lines was evaluated by examination of serial sections from whole mount stained embryos with the following arbitrary scale 
of stained nuclei: -,  no labeled nuclei;  ---, rare labeled nuclei at only a few locations;  +, a few labeled nuclei at multiple locations or numerous labeled nuclei at a few locations; 
+ +, numerous labeled nuclei at multiple locations or a few labeled nuclei at most locations or most nuclei labeled at a few locations; + + +, most nuclei labeled at multiple loca- 
tions or numerous nuclei at most locations;  + + + +, most nuclei labeled at most locations. For most lines, the founder was sacrificed at the indicated embryonic age. 
~CNS, central nervous system. 
liThe founder was sacrificed at the indicated embryonic age. 
1 Determined by immunohistochemistry and in situ hybridization experiments (Marvuni et al., 1996). Arbitrary scale from no (-) to very intense (+ + + + ) staining. 
ittal section of the hindlimb of Fig. 3 A, where the SMAS 
(arrows) inserted into the skin. At the insertion sites, mes- 
enchymal cells accumulated very close to the epithelium 
and  fibrillar  structures  from  the  connective  tissue  sur- 
rounding  the  superficial  fascia  converged  toward  them 
(Fig. 3 B). A  similar picture was detected in the armpit 
(Fig. 3 C), and, in some embryos, in the eyelids (Fig. 3 D). 
We interpret the latter localization as the site of anchorage 
of the palpebral connective tissue which envelops the or- 
bicular ocular muscle to the conjunctiva and the skin of 
eyelids. An interesting detail of Fig. 3 D is that the cutane- 
ous muscle converges toward the X-gal stained structures. 
The same organization was found in the region in front of 
the ear (Fig. 3 E). In this case, however, 13-galactosidase 
staining  accumulated  where  the  superficial  aponeurosis, 
rich  in  muscle  fibers,  intersected the  ear  cartilage.  The 
proposed tissue architecture is illustrated in Fig. 3 F for the 
skin. 
Tendons. Expression of lacZ reporter gene in  tendons 
was detected in all the transgenic lines examined. Tendons 
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of  transgenes  with  regulatory  sequence 
shorter than 4.0 kb. Whole mount staining. 
(A and B) Embryos of line 0.61acZ57 at 13.5 
(A) and 12.5 d (B). (C and D) Upper and 
lower limbs of an embryo of 16.5 d of the 
same line. (E) Embryo of line 1AlacZ1. (F) 
Embryo  2.81acZ1. Labeling  is  found  in 
limbs, in a region in front of the ear and at 
the internal side of the root of the limbs (B, 
arrows) in all embryos, and, with lower fre- 
quency, in the eyelids (F). The capsules be- 
tween the first and the second phalanges are 
also labeled in embryo 2.81acZ1 (F). Among 
this group of embryos, staining in phalanges 
was unique to 2.81acZ1. 
in the tail were among the most reactive (Fig. 4 A) and la- 
beled cells were found throughout their structure  (data 
not shown). In other locations staining was mainly at the 
periphery of the tendon, in the peritenoneum (Fig. 4 B), 
and  at the bone-tendon junction. This was very clear in 
sections from adult animals, where the surface of insertion 
of tendon on bone was larger (Fig. 4 C). All the sites ex- 
pressing the transgene were strongly stained with antibod- 
ies to collagen VI (data not shown). 
Joints and Intervertebral Disks. When the 5'-flanking re- 
gion of the constructs was increased to 5.4-kb or to 6.2-kb, 
[3-galactosidase reaction became detectable in five addi- 
tional tissues: joints, intervertebral disks, nerves, subepi- 
dermal mesenchyme, and vibrissae in all the lines (Table I). 
These same tissues were positive in all lines with a regula- 
tory sequence extending to -7.5 kb from the transcription 
start site [constructs 7.5A(3.0-1.1)lacZ and 7.51acZ] (Table I) 
and the data will therefore be presented in the same fig- 
ures  for all  these  constructs.  Stain  deposition  in joints 
was particularly strong in articular cartilage of large diar- 
throses where it was apparent also in whole mount prepa- 
rations when the  superficial tissues were poorly labeled 
(Fig. 5 A). Only a few cell layers underneath the articular 
surface were positive, whereas the bulk of cartilage was 
negative (Fig. 5, B and C). Articular cartilage of small di- 
arthroses was less frequently stained; this happened usu- 
ally with longer constructs (Fig. 5 D). In transgenic animals 
carrying the longest regulatory region, the synovial mem- 
brane was also stained (Fig. 5 C). Intervertebral disks were 
among the tissues exhibiting highest reactivity (Fig. 5 E). 
Nerves. J3-Galactosidase staining associated with nerves 
was primarily studied in the mouse line 7.51acZ8,  but the 
Braghetta et al. Tissue Specific Expression of otl(Vl) Collagen  l 167 Figure 3.  Histological analysis demonstrating expression of transgenes at sites of insertion of the SMAS. (A) Parasagittal section of the 
left hindlimb of embryo of line 5.41acZ3 showing insertions of SMAS at the posterior surface of limb; SMAS is indicated by arrows. (B) 
Enlarged view of the site of insertion shown in A. (C) Armpit of embryo of line 5.41acZ1. (D) Oblique section through right eye of em- 
bryo of line 2.81acZl; note that SMAS (arrows) converges toward the [3-galactosidase  positive region which contacts the basal surface of 
the epithelium of conjunctiva. (E) Section through right external ear of embryo of line 2.81acZ1 showing anchoring of SMAS (arrows) to 
the ear cartilage primordium. (F) Drawing illustrating cutaneous and subcutaneous tissue (SCT) with SMAS and its skin insertion sites. 
Bars: (A, D, and E) 200 vLm; (B and C) 100 i~m. 
The Journal  of Cell Biology,  Volume 135, 1996  1168 Figure 4.  Transgenes  expression  in tendons.  (A) Whole mount 
staining of embryo of line 6.21aeZ2 showing tendons of the tail. 
(B) Frozen section of tendon of the right tibialis anterior muscle 
from a 16.5-d-old embryo of line 7.51acZ8; blue X-gal reaction 
products are detectable mainly at the periphery of the tendon 
and in the peritenoneum. (C) Section of lateral head of gastroc- 
nemius muscle from an adult mouse of the 7.51acZ8 line. 13-Galac- 
tosidase staining is particularly intense in tendon cells close to the 
bone. Bar, 100 p~m. 
data were confirmed in all the embryos with constructs in- 
cluding the sequen.ce from  -4.0  to  -5.4.  Faint  labeling 
was first detectable as scattered groups of cells in the dor- 
sal and lateral body wall and in the proximal part of the 
upper limb at 11.5 d (data not shown). One day later, the 
reaction was stronger and appeared as a  superficial net- 
work which extended ventrally with a sharp border in the 
body wall, reached the forearm in the upper limb and be- 
gan to expand into the lower limb (Fig 6 A). In the follow- 
ing days the network invaded completely the ventral re- 
gion and propagated to the tip of the fingers (Fig. 6 B). 
The neck (Fig. 6, A  and B) was also stained. In the head, 
labeling was weaker and was slightly enhanced in the tem- 
poral  and  in  the  frontal regions  (data  not  shown).  The 
identity of the  observed structures  as  nerves was  estab- 
lished by histological analysis of serial sections (Fig. 6, C, 
D, and E). Stained cells sharply delimited the perimeter of 
monofascicular nerves (Fig. 6 E). Additional information 
on the location of the labeled cells with respect to the axon 
bundles was obtained by staining the same cryostat section 
histochemically for ~-galactosidase  and  immunologieally 
with antibodies specific for neurofilaments and  type VI 
collagen (Fig. 7). Reactive cells were found in contact with 
axon bundles of different sizes (Fig. 7, A and C). In larger 
axon  associations  the  cells  were  almost  exclusively de- 
tected at the periphery. This is particularly evident in Fig. 
7, C, D, and E, which show an oblique section of a nerve: 
on the left side, where the innermost part of the nerve has 
been sampled, labeled nuclei border the axon bundle; on 
the right side, where the section cuts the nerve tangen- 
tially, stained nuclei overlap with a region immunofluores- 
cent for neurofilaments and strongly positive for collagen 
type VI. 
Vibrissae and Subepidermal Mesenchyme.  Mesenchymal 
cells surrounding vibrissae were positive in embryos with 
promoter fragments larger than 4.0 kb (Table I; Figs. 5 A, 
6 B, 8 A, and 9 A). In addition, two out of seventeen lines 
with  the  promoter region  shorter than  4.0  kb  also  had 
staining in this tissue  (lines 2.81acZ1  and 4.01acZ3). It is 
worth noting that  both lines had multiple  copies of the 
transgene. X-gal positive cells were found in the loose con- 
nective tissue under the skin. The nature of these cells is 
unknown and, given their fibroblast-like morphology, they 
can be generally classified as mesenchymal cells. Staining 
of this subepidermal mesenchyme was apparent only rela- 
tively late (after 14.5-15.5 d of gestation) and was faint in 
most  embryos,  excepting those  of the  7.51acZ8  line,  in 
which labeled nuclei were more abundant in the subcuta- 
neous tissue; in the dermis positive cells were often close 
to hair follicles (Fig. 8 B). 
Skeletal Muscle. Transgenic embryos generated with con- 
structs including the entire 7.5-kb of 5'-flanking sequence 
(7.51acZ) or a fragment with an internal deletion in the 3' 
region [7.5A(3.0-1.1)lacZ],  expressed 13-galactosidase at high 
levels in the tissues described above (Table I). In addition, 
positive cells were found in skeletal muscle, particularly in 
the two lines 7.51acZ8  and 7.51acZ62.  Very faint staining 
with  a  metameric pattern  was  first  detectable  in  whole 
mount preparations of ll.5-d embryos in the dorsolateral 
region (data not shown). At 13.5 d, strongly reactive mus- 
cle masses were located in the lateral body wall (Fig. 9 A), 
in the dorsal region as a long thread bordering the verte- 
bral column (Fig. 9 B), and in the limbs (Fig. 9, A  and B). 
Histological examination revealed that different muscles 
stained with different intensity (Fig. 9 C and Fig. 6 E). In- 
terestingly, however, the pattern  of muscle labeling was 
similar in the various lines and embryos (compare Fig. 9 C 
with Fig, 6 C). At high microscopic magnification, it was 
apparent that 13-galactosidase  reaction was predominant in 
mononuclear cells surrounding the muscle fibers (Fig. 9 D). 
Very often it could not be established if the labeled nuclei 
belonged to  the  mononuclear cells or  to  the  myotubes. 
Thus, we cannot exclude at the moment the possibility that 
the transgenes were expressed by the muscular elements. 
X-gal positive nuclei were also detected in adult muscle 
(Fig. 9 E). Most nuclei were clearly located within the con- 
nective tissue; however, some were very flat and closely 
Braghetta  et al. Tissue  Specific  Expression  of t~l(Vl) Collagen  1169 Figure5.  Expression ofthe lacZ constructs in joints andintervertebrad disks. (A) Whole mount preparation ofembryo 5.41acZA;  deposi- 
tion of X-gad stain in scapulo-humeral, elbow, and knee articulations (arrows) can be seen through the superficial tissues, which contain 
a faintly positive network. (B) Section of the elbow joint of embryo of line 5.41acZ2; labeling is mainly located in the articular cartilage. 
(C) Scapulo-humerad joint from a 16.5-d-old embryo of the line 7.51acZ8; both articular cartilage and the synoviad membrane are posi- 
tive. (D) Strong staining of intervertebrad diarthroses in a 16.5-d embryo of the 7.51acZ8 line; note absence of labeled nuclei in the kid- 
ney (k), in the adrenal gland (ag), andin the pyloric  part of the stomach (s). (E) Sagittad section of embryo of line 7.5A(3.0-1.1)IacZ3;  the 
entire intervertebrad disks express 13-galactosidase; lung (/) is negative, whereas spinal cord (sc) is darkly stained. Bars: (B and D) 200 
~m; (C and E) 100 Ixm. 
The Journal  of CeU Biology,  Volume 135, 1996  1170 Figure 6.  Expression of lacZ transgenes in nerves. (A) Whole mount staining of a 12.5-d embryo of the line 7.51acZ8. (B) Whole mount 
preparation of embryo of line 5.41acZ3 (15.5 d). (C) Cross section of a 13.5-d 7.51acZ8 embryo; staining is evident in nerve branches of 
different size; g, gonad; li,  fiver; sc, spinal chord.  (D)  Section through superficial tissues of embryo of fine 7.5A(3.0-1.1)IacZ3.  (E) 
Parasagittal section of a 16.5-d embryo of line 7.51acZ8; positive cells form an epithelioid layer around intercostal nerves (arrows). Bars: 
(C and E) 100 ~m; (D) 25 p,m. 
Braghetta et al. Tissue Specific Expression of ctl  (Vl) Collagen  1171 Figure 8.  Expression of lacZ gene in mesenchyme of vibrissae 
(A) and in the skin (B) in a 16.5-d embryo of the line 7.51acZ8. 
The extension of dermis (d) and subcutaneous tissue (st) are indi- 
cated. The subcutaneous tissue is split in a superfieiai  and a deep 
layer by the presence of the SMAS, in which a thin sheet of cuta- 
neous muscle can be seen. Arrow in B points out a hair follicle. 
Bars: (A) 200 ~m; (B) 100 ~m. 
Figure 7.  Association of transgene  expressing  ceils  with  axon 
bundles. Frozen sections were cut from 14.5-d  embryos of the 
7.51acZ8 line and processed for 13-galactosidase histochemical re- 
action. The sections were then stained with a monoclonal anti- 
body against neurofilaments and a rhodaminated secondary anti- 
body, an  antibody specific  for mouse type VI collagen and  a 
fluoresceinated secondary antibody and with HOECHST dye. A, 
C, D, and E were taken with double exposure of bright field and 
fluorescence optic.  (A)  A  superficial  axon bundle  (rhodamine 
stained) of the thoracic wall and associated 13-galactosidase posi- 
tive cells. (B) The same field of A observed for HOECHST fluo- 
rochrome to localize nuclei.  (C) Distribution of 13-galactosidase 
positive cells  in a  large axon bundle  (rhodamine  stained);  the 
cells are observed mainly at the periphery of the nerve. (D) The 
same section of C showing the distribution of collagen VI (fluo- 
resceine stained); the protein is abundant around the nerve, but is 
also detectable in the surrounding connective tissue.  (E) Same 
section of C and D observed under double immunofluorescence; 
extensive overlapping of staining for neurofilaments and type VI 
collagen in the right part of the picture is indicated by yellow fluo- 
rescence. Bar, 25 ~m. 
associated with the myofibers in a way expected for nuclei 
of the  myotubes or of satellite  cells.  Staining  in skeletal 
muscle was also detected  in ~15%  of the lines with  the 
promoter fragment not including the region -6.2 to -7.5 
(Table I). 
Meninges. Lines with a  transgene containing the region 
from -7.5 to -6.2 exhibited expression in meninges. With 
shorter  constructs  only  two  embryos  showed  labeled 
meninges, one of which had a high transgene copy number 
(Table I). An example of labeling of meninges can be seen 
in Fig. 9 C. 
Ectopic Expression. The  central  nervous  system  and/or 
the retina, which are not collagen VI producers, were reac- 
tive  for  13-galactosidase  in  32  out  of 34  transgenic  lines 
(Table I). In the central nervous system staining was usu- 
ally detected in the telencephalon and in the spinal cord. 
Examples  of staining  in  the  central  nervous  system  and 
retina can be found in Figs. 2 A, E, F, 5 E, 9, A  and B. 
Further Analysis of the Promoter Region from 
-4.0  to  -  7.5 
The data reported above suggest that the 7.5-kb fragment 
flanking the 5' end of the al(VI)  gene contains positive- 
acting elements which stimulate high level transcription in 
The Journal of Cell Biology, Volume 135, 1996  1172 Figure 9.  Expression of transgenes in skeletal muscle. (A and B) Lateral and back view of a 13.5-d embryo from the line 7.51acZ62. (C) 
Histological section showing that the deep blue staining of embryo in A and B is located in skeletal muscles; meninges (arrow) are also 
labeled. (D) Frozen section from 16.5-d embryo of line 7.51acZ8. (E) Muscle from an adult mouse; several X-gal labeled nuclei belong to 
connective tissue cells; some are very fiat and closely associated with the myotubes as expected for nuclei of muscle fibers or of satellite 
cells (arrows). Bars: (C) 200 Ixm; (D) 25 I~m; (E) 50 p~m. 
nine tissues where type VI collagen is normally expressed, 
including  insertion  of  superficial  aponeurosis,  tendons, 
joints, intervertebral disks,  nerves, subepidermal mesen- 
chyme, vibrissae, skeletal muscle, and meninges. Except- 
ing the first two, the elements for the other seven tissues 
are  apparently located in  the region  -4.0 to  -7.5.  The 
analysis of Table I, however, does not tell us if different 
portions of this large region are equally effective as induc- 
ers.  In addition, for some other tissues, notably skeletal 
muscle and meninges, 13-galactosidase  expression was al- 
ways present with the longest constructs, but was also ob- 
served at low frequency in transgenic lines with shorter 
constructs.  These  results  cannot  distinguish  between  a 
model which localizes the active sequence in the far up- 
stream region and models which consider the more fre- 
quent  expression  in  the  longest  constructs  as  a  conse- 
quence either of promoter insulation by the larger DNA 
fragment or of a scattered distribution of weak activating 
elements. To throw light on these issues, 23 transgenic lines 
were produced with the constructs delineated in Fig. 1 B, 
which were obtained by fusing the proximal 1.4-kb of the 
etl(VI) promoter with either fragment -4.0 to -5.4 [con- 
struct 5.4A(4.0-1.4)lacZ]  or fragment -5.4 to -6.2 [construct 
6.2A(5.4-1.4)IacZ]  or  fragment  -6.2  to  -7.5  [construct 
7.5A(6.2-1.4)IacZ].  The  distribution  of X-gal  staining  for 
these lines in the nine relevant tissues is reported in Table 
II and can be summarized as follows. (a) As expected by 
the presence of the proximal 1.4-kb fragment, all the lines 
expressed the transgene at the site of insertion of superfi- 
cial aponeurosis and in tendons. (b) Activation in nerves 
was conferred only by fragment -4.0 to -5.4. (c) Inducing 
activity in the vibrissae and in the subepidermal mesen- 
Braghetta et al. Tissue Specific Expression of ctl(Vl) Collagen  1173 Figure 10.  Constructs 7.5A(6.2-1.4)lacZ and 5.4D(4.0-1.4)lacZ are expressed in different domains of the region of vibrissae. (A and B) 
Whole mount X-gal staining of embryos of lines 7.5A(6.2-1.4)lacZ8 and 5.4A(4.0-1.4)IacZ7. (C and D) Histological picture of the area 
shown in A and B, respectively. Bar, 100 ~m. 
chyme was present in the -4.0 to -5.4 and -6.2 to -7.5 
sequences, but was absent in the -5.4 to -6.2 fragment. 
Interestingly, staining differed between the two constructs 
5.4A(4.0-1.4)lacZ and 7.5A(6.2-1.4)lacZ. In 7.5A(6.2-1.4)lacZ 
lines strongly positive vibrissae were located in the ven- 
tral-posterior  quadrant  (Fig.  10 A). This same  area was 
poorly stained in the 5.4A(4.0-1.4)lacZ  lines, in which la- 
beling was detected in the remaining quadrants  (Fig.  10 
B). Significant differences were also observed at the histo- 
logical level: in 7.5A(6.2-1.4)lacZ  lines X-gal labeled nuclei 
were  more  abundant  in  the  outer  layers  of the  dermal 
sheath and in the mesenchyme between follicles (Fig. 10 
C), whereas in 5.4A(4.0-1.4)lacZ  lines [3-galactosidase  pos- 
itive cells were almost exclusively found in the inner layers 
of the dermal sheath and in the dermal papilla (Fig. 10 D). 
(d) Joints and intervertebral disks were positive in all the 
transgenic lines with construct 5.4A(4.0-1.4)lacZ,  and in 9 
out of 11 lines with construct 7.5A(6.2-1.4)lacZ,  whereas, 
out of 5 lines obtained with construct 6.2A(5.4-1.4)lacZ, 
only one, with multiple transgene copies, showed labeling. 
(e) High frequency of activation (100% of lines) in muscle 
and meninges was found when the region  -6.2  to  -7.5 
was present [7.5A(6.2-1.4)lacZ  lines]. Among the remain- 
ing lines, labeling could be detected only in one 5.4A(4.0- 
1.4)lacZ line for each tissue. 
Discussion 
The main conclusion suggested by the  experiments pre- 
sented in this study is that the transcriptional activation of 
the od(VI) collagen gene in different tissues during em- 
bryonic development is regulated by multiple cis-acting 
elements scattered over several kilobases of genomic se- 
quence. The region analyzed extends from the transcription 
start site to 7.5 kb upstream and contains sequence infor- 
mation for expression in several collagen VI producing tis- 
sues, including sites of insertion of superficial and muscu- 
lar aponeurosis, tendons, joints, intervertebral disks, nerves, 
subepidermal mesenchyme, vibrissae, skeletal muscle, and 
meninges. This is only a subset of the organs which express 
type VI collagen in their connective tissue (Marvulli et al., 
1996).  Thus,  transgenes  were  not  active  in  the  mesen- 
chyme of the digestive tract and the adjacent glands, in the 
lung, in the kidney, in the cornea, in the periostium and 
perichondrium, in the gonads, and in the adrenal glands. 
Our suggestion is that, in all these organs, transcription is 
dependent on regulatory sequences  not included in  the 
DNA genomic fragment studied here. Preliminary experi- 
ments in which we have extended our analysis to the re- 
gion from -7.5  to  -14.0 kb confirm this conclusion: the 
addition  of this  region  apparently  activates  [3-galactosi- 
The Journal of Cell Biology, Volume 135, 1996  1174 Table II. Analysis of Tissue Specific Activating Sequences in the Promoter Region -4.0 to -7.5* 
Tissues 
Age of  Insertion of  Tendons  Inter-  Vibrissae 
Copy  embryos  superficial  and  vertebral  Subepidermal  (mesen-  Skeletal 
Line  number  (days)  aponeuroses  ligaments  Joints  disks  Nerves  mesenchyme  chyme)  muscle  Meninges 
5.4A(4.0-1.4)lacZ1  1  14.5  ++++  +  +++  ++  ++++  _+  ++  -  + 
5.4A(4.0-1.4)lacZ2  1  14.5  +  +  +  _+  _+  +  ___  +  -  - 
5.4A(4.0-1.4)lacZ3  1  15.5  +  +  +  +  +  +  +  +  +  +  -  +  _+  - 
5.4A(4.0-1.4)lacZ4  1  15.5  ++  ++  ++  ++  ++++  _+  +++  -  - 
5.4A(4.0-1.4)lacZ5  1  15.5  +  +  +  +  +  +  _+  +  -  - 
5.4A(4.0-1.4)lacZ6  1  15.5  +  +  +  +  +  +  +  +  -  - 
5.4A(4.0-1.4)lacZ7  1  15.5  ++  +  +++  +++  +++  +  +++  -  - 
6.2A(5.4-1.4)lacZ1  4  15.5  +  +  +  +  +  + 
6.2A(5.4-1.4)lacZ2  1  15.5  +  ___  -  - 
6.2A(5.4-1.4)lacZ3  1  15.5  +  +  +  -  - 
6.2A(5.4-1.4)lacZ4  1  15.5  +  _+  -  - 
6.2A(5.4-1.4)lacZ5  4  15.5  +++  +  -  - 
m 
m 
7.5A(6.2-1.4)lacZ1  1  14.5  +  +  +  -  -  -  +  +  +  +  +  + 
7.5A(6.2-1.4)lacZ2  1  14.5  +  +  ....  +  ++  + 
7.5A(6.2-1.4)lacZ3  1  15.5  +  +  +  +  ___  +  +  -  +  +  +  +  +  +  +  + 
7.5A(6.2-1.4)lacZ4  1  15.5  +++  ++  +  ++  -  +  ++  +++  + 
7.5A(6.2-1.4)lacZ5  1  15.5  +  +  +  +  +  -  +  +  +  +  +  + 
7.5A(6.2-1.4)lacZ6  1  15,5  ++++  ++  ++  +++  -  ++  +++  +++  +++ 
7.5A(6.2-1.4)lacZ7  1  15.5  +++  +++  +  +  -  +  +++  +++  +++ 
7.5A(6.2-1.4)lacZ8  1  15.5  +++  ++  ++  +++  -  +  +++  +++  ++ 
7.5A(6.2-1.4)lacZ9  1  15.5  +++  +  _+  +++  -  +  +++  +++  ++ 
7.5A(6.2-1.4)lacZ10  1  15.5  +  +  +  +  +  +  +  -  ___  +  +  +  +  + 
7.5A(6.2-1.4)lacZ11  10  15.5  ++  ++  +  +++  --  +  ++  +++  ++ 
Conuol §  9.5m16.5  ++++  +++  ++++  ++++  +++  ++++  ++++  ++++  +++ 
*The region -4.0 to -7.5 was studied producing transgenic animals with the three constructs defined in Fig. 1 B. The founder animals were sacrificed at the embryonic age indi- 
cated and analyzed for ~-galactosidase expression as detailed in footnote* of Table I. 
~Determined by immunohistochemistry and in situ hybridization experiments (Marvulli et al., 1996). Arbitrary scale from no (-) to very intense (+ + + +) staining. 
dase expression in several other tissues, including lung, di- 
gestive  tract,  and  cornea  (Braghetta,  P.,  manuscript  in 
preparation).  On  the  other  hand,  transgenes  were  ex- 
pressed in the central nervous system and in the retina, tis- 
sues where collagen VI was not detected (Marvulli et al., 
1996). Ectopic induction of transgenes in the central ner- 
vous system has been observed with promoters for type I col- 
lagen  chains  (Niederreither  et  al.,  1992;  Rossert  et  al., 
1995; Sokolov et al., 1995). In experiments comparable to 
those described here, however, a much lower frequency in 
different lines has been reported (~30%: Niederreither et al., 
1992) compared to ours (~95%). The reason for this high 
frequency of activation is not known; one possibility is that 
negatively acting elements normally suppress transcription 
of etl(VI)  in the central nervous system and retina and 
that  these sequences are not contained in the promoter 
fragments we have studied. 
As for the collagen VI-producing tissues where the trans- 
genes were expressed with high frequency, analysis of Ta- 
bles I and II suggests the following conclusions on the tran- 
scriptional regulation of al(VI) (summarized in Fig. 11). 
(A) In all the transgenic lines examined expression was 
active at low levels in tendons and, at high levels, in dis- 
crete areas of the limb buds, in the armpit and the groin 
and in front of the ear. The latter distribution of 13-galac- 
tosidase staining was rather odd, being detected in appar- 
ently  unrelated  locations.  Careful  histological  analysis, 
however, revealed staining of cells at the sites of insertion 
of the superficial and muscular aponeurosis as a common 
motif. These sites were the skin and the ear cartilage. The 
superficial aponeurosis is a fibrous connective tissue which 
divides the  subcutaneous  tissue  into a  superficial  and  a 
deep layer (see Fig.  3  F).  In most mammals  it contains 
skeletal muscle fibers, the cutaneous muscles (see Fig. 8 B), 
also known as panniculus carnosus, which have the func- 
tion to move the skin. In human, this tissue has been very 
well studied  and  has  been designated  SMAS  (Mitz and 
Peyronie, 1976), a term which has been adopted here also 
for the  mouse to stress  its  fascial  (aponeurotic) nature. 
Human SMAS does not contain muscle in most body loca- 
tions except in the face where it envelops the facial mus- 
cles, which are important in determining the characteristic 
expression of each person. It is worth noting that the hu- 
man SMAS of the face attaches posteriorly to the tragus 
and penetrates anteriorly into the fibers of the orbicular 
muscle of the eye. The corresponding locations of mouse 
embryos contained cells expressing the transgenes at high 
levels. Our immunohistochemical results (Marvulli et al., 
1996) indicate that collagen type VI is particularly abun- 
dant at the sites of insertion of SMAS. The surrounding 
dermis, however, contains collagen VI too. This situation 
may explain why this particular area of collagen type VI 
deposition has not been noted previously. 
Positively acting elements for insertion of SMAS  and 
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Figure  11.  Summary  of the distribution  of regulatory regions 
controlling tissue-specific expression of the al(VI) collagen gene. 
Only regions producing high frequency X-gal staining in the dif- 
ferent transgenic lines are indicated. For a particular  promoter 
region,  tissues in which 13-galactosidase expression  was strong 
(see scale in Table I) are in bold letters. Arrow indicates the tran- 
scription initiation site of the gene; El, E2, first, and second exon. 
The sequence examined in this study is represented by the con- 
tinuous thick line. S.A., superficial aponeurosis; i.v. disks, inter- 
vertebral disks. 
tendons are contained within the first 600 bp upstream of 
the transcription start site. In fact, all the lines generated 
expressed the reporter gene in these tissues and the 600-bp 
are the only promoter sequence common to the different 
transgenes. A  confirmation of this conclusion comes from 
recent experiments on the production of transgenic lines 
with lacZ constructs similar to those of Fig. 1 B in which 
the 1.4-kb fragment of the ed(VI) promoter has been sub- 
stituted by the human  B-globin basal promoter (55 bp). 
Preliminary data  have  shown  that  a  B-globin  construct 
containing the fragment -4.0 to -5.4 of the cd(VI) pro- 
moter had a tissue pattern of expression equivalent to the 
corresponding  5.4A(4.0-1.4)lacZ  constructs  with  the  ex- 
ception of insertions of SMAS and tendons, where expres- 
sion was missing (Braghetta, P., unpublished results). 
(B)  Transcriptional  induction  in joints,  intervertebral 
disks,  subepidermal  mesenchyme, and nerves was  abso- 
lutely dependent on sequences located upstream of -4.0. 
The data reported in Table II indicate that the region from 
-4.0  to  -7.5  contains  more  than  one c/s-activating  se- 
quence for joints, intervertebral disks,  and subepidermal 
mesenchyme. In particular, one element(s) is located be- 
tween  -4.0  and  -5.4  and a  second element(s) between 
-6.2 and -7.5. In addition, a third element(s) with low ac- 
tivity for joints and intervertebral disks may be contained 
in  the  fragment  -5.4  to  -6.2,  since  one  of  the  two 
6.2A(5.4-1.4)lacZ  lines with multiple transgene copies exhibited 
~-galactosidase expression. 
On the other hand, sequences responsible for expression 
in nerves were restricted to the region -4.0 to -5.4. Po- 
tential cell types expressing the transgenes include Schwann 
cells, fibroblasts, and perineurial cells, all of which have 
been shown to produce type VI collagen in human (Pel- 
tonen et al., 1990). Preliminary experiments from our lab- 
oratory  have  revealed  that  the  X-gal  positive  cells  in 
nerves stain for markers of peripheral glia, suggesting that 
they likely belong to the Schwann cell lineage (Vitale, P., 
manuscript in preparation). At the moment, however, we 
cannot  exclude the  possibility that  fibroblasts  and  peri- 
neurial cells also express the transgene. The existence of 
cis-acting elements regulating specific transcription of the 
ed(VI) collagen chain in nerves suggests a special role of 
type VI collagen in this tissue. Given the early stage of ac- 
tivation of the transgene (11.5-d embryo) and the rapid in- 
crease of its expression, one attractive hypothesis is that 
collagen VI favors the initial morphogenesis of the nerves. 
(C) Expression of the transgenes in the mesenchyme of 
vibrissae was strongly dependent on the regions -4.0 to 
-5.4 and  -6.2 to  -7.5. However, expression at low fre- 
quency was also observed with constructs 2.81acZ  (1 in 4 
lines) and 4.01acZ  (1 in 7 lines). The interpretation of this 
result is that either transcription was induced by the par- 
ticular site of insertion of the transgene in these lines or 
the region between -1.4 and -4.0 comprises positive reg- 
ulatory sequences with low activity. The latter interpreta- 
tion seems more likely, since the two expressing lines have 
multiple copies of the transgene, a condition which favors 
expression of weak promoters. Transcription in different 
domains of the area of vibrissae and of different layers of 
mesenchyme around the follicles are dependent mainly on 
two distinct promoter regions. This finding suggests an un- 
expected complexity in the cell population of this mesen- 
chyme. Expression of different transgenes may therefore 
be considered a useful marker for the characterization of 
the two cell groups. 
(D) Strong activating sequences for skeletal muscle and 
meninges were present in the fragment -6.2 to -7.5. Con- 
siderations similar to those discussed under C for vibrissae 
lead to the conclusion that additional weak stimulatory se- 
quences may be located also outside this fragment. The ex- 
act position of the elements is difficult to identify, due to 
the low frequency and low level of X-gal staining with con- 
structs lacking the region -6.2 to -7.5. As for muscle, the 
sporadic expression could be accounted for by the pres- 
ence of a single weak element within -1 and 600 bp, but 
other  possibilities  cannot  be  ruled  out.  In  the  case  of 
meninges,  the  minimum  number  of weak  activating se- 
quences  deduced from the  experiments is  two,  one be- 
tween -1.4 and -2.8, the other between -4.0 and -5.4. 
Collagen VI is produced in high quantities in skeletal 
muscle, where it is deposited very close to the surface of 
the myotubes (Marvulli et al., 1996). Collagen VI expres- 
sion by myoblasts in vitro is low in the logarithmic phase 
of proliferation, increases quickly when subconfluent cells 
are induced to differentiate and declines before myotubes 
appear (Piccolo et al.,  1995).  Assuming that myoblasts in 
vivo have the same behavior, one would expect that high 
transgene expression will be detectable in myoblasts just 
before fusion, will become very low in fusing myoblasts, 
and will be absent in fully developed myotubes. Since, as 
reported for other systems, [3-galactosidase is an appropri- 
ate reporter gene to follow the temporal expression of a 
promoter during development (Sham et al., 1993), staining 
should be found frequently in mononuclear cells, while 
13-galactosidase  activity should be almost undetectabie in 
myotubes. This expected expression pattern of the etl(VI) 
promoter precludes a clear identification of the cells pro- 
ducing the transgene based on morphological data only. 
To settle this issue will require labeling with probes for 
specific markers of myoblasts. Characteristically, the ex- 
pression levels of the transgenes varied in different mus- 
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relative intensity was similar in the various positive mouse 
lines. Since no such differences could be detected  in the 
expression of the endogenous ctl(VI) gene by in situ hy- 
bridization  and  immunohistochemistry  (Marvulli  et  al., 
1996), it should be concluded that the 7.5-kb of regulatory 
sequence analyzed here contains only partial information 
for transcriptional activation in skeletal muscle. 
Since type VI collagen is widely distributed and found in 
most connective tissues, one would expect a simpler regu- 
lation of its genes.  However, a thorough analysis of type 
VI collagen products during development has unveiled an 
elaborate pattern of expression (Marvulli et al., 1996). For 
example,  the  mRNA  steady-state  levels  are  first detect- 
able in the various tissues at different stages and show dif- 
ferent  dynamics  in  embryonic  and  postnatal  life;  more- 
over, at variance with type I collagen, the  abundance  of 
both mRNA and protein in the connective tissues under- 
neath  epithelia  is  not  homogeneous,  but  decreases  with 
the distance from the basement membrane. Complex pat- 
terns of expression have been described for other proteins 
of the extracellular matrix, but information on their tran- 
scriptional  regulation  is usually limited.  An  exception  is 
type I collagen, for which numerous studies on promoter 
activity in transgenic animals are available (Niederreither 
et al., 1992; Pavlin et al., 1992; Liska et al., 1994; Rossert 
et al., 1995; Sokolov et al., 1995). Overall, these studies fa- 
vor the idea that separate cell-specific cis-acting elements 
activate collagen I genes in different type I collagen-pro- 
ducing cells. This modular arrangement of regulatory ele- 
ments would endow type I collagen, and, as suggested in 
this study, type VI collagen chains, with a great potential 
of adjusting  expression  levels  at  adequate  locations  and 
times  during  complex  developmental  processes  such  as 
those of tissue and organ morphogenesis. 
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